sk&f 105809 has been researched along with arachidonic acid in 4 studies
| Studies (sk&f 105809) | Trials (sk&f 105809) | Recent Studies (post-2010) (sk&f 105809) | Studies (arachidonic acid) | Trials (arachidonic acid) | Recent Studies (post-2010) (arachidonic acid) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 19,295 | 486 | 3,040 |
| Protein | Taxonomy | sk&f 105809 (IC50) | arachidonic acid (IC50) |
|---|---|---|---|
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 4.5 | |
| Fatty acid-binding protein, adipocyte | Homo sapiens (human) | 2.75 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 4.5 | |
| 60 kDa chaperonin | Escherichia coli | 7.3 | |
| 10 kDa chaperonin | Escherichia coli | 7.3 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.0715 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.6026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griswold, DE; Marshall, P; Martin, L; Webb, EF; Zabko-Potapovich, B | 1 |
| Bender, PE; Breton, J; Griswold, DE; Hanna, N; Hillegass, LM; Lee, JC; Marshall, PJ; Newton, J; Sarau, HM; Webb, EF | 1 |
| Griswold, DE; Hanna, N; Hillegass, LM; Lee, JC; Marshall, PJ; Newton, J; Wartell, J; Webb, EF | 1 |
| Adams, J; Bender, P; Dimartino, MJ; Griswold, DE; Hanna, N; Kirsh, R; Marshall, PJ; Newton, J; Schwartz, L | 1 |
4 other study(ies) available for sk&f 105809 and arachidonic acid
| Article | Year |
|---|---|
Analgetic activity of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Benzoquinones; Cyclooxygenase Inhibitors; Female; Imidazoles; Lipoxygenase Inhibitors; Male; Mice; Pain; Rats; Rats, Inbred Strains | 1991 |
Pharmacology of the pyrroloimidazole, SK&F 105809--I. Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
Topics: Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Cytokines; Eicosanoids; Humans; Imidazoles; Inflammation; Interleukin-1; Leukotrienes; Lipoxygenase Inhibitors; Male; Phospholipases; Phospholipids; Prodrugs; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Lew | 1991 |
Pharmacology of the pyrroloimidazole, SK&F 105809--II. Antiinflammatory activity and inhibition of mediator production in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Dermatitis, Contact; Edema; Eicosanoids; Imidazoles; Inflammation; Male; Mice; Mice, Inbred BALB C; Prodrugs | 1991 |
Pharmacological profile of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.
Topics: Administration, Oral; Analgesics; Animals; Arachidonic Acid; Arachidonic Acids; Arthritis, Experimental; Collagen; Cyclooxygenase Inhibitors; Eicosanoids; Gastric Mucosa; Humans; Imidazoles; Indomethacin; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred Strains; Otitis Externa; Peritonitis; Rats; Rats, Inbred Lew; Stomach Ulcer | 1990 |